DoJ Sets Its Sights On DESI Drugs: Eon Labs Settles Claims It Marketed An Ineffective Drug

Novartis subsidiary agrees to pay $3.5 million to settle claims it illegally sought government reimbursement for Nitroglycerin SR after FDA found it to be less than effective.